Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure.

NCT00572455 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

318

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Open-Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: PF-04217329 - Lowest Dose
DRUG: PF-04217329 - Low Dose
DRUG: PF-04217329 - Middle Dose
DRUG: PF-04217329 - High Middle Dose
DRUG: PF-04217329 - High Dose
DRUG: PF-4217329 - Highest Dose
DRUG: PF-04217329 - Vehicle
DRUG: Latanoprost Vehicle
DRUG: PF-04217329 - Low Dose
DRUG: Latanoprost Vehicle
DRUG: PF-04217329 - Middle Dose
DRUG: Latanoprost Vehicle
DRUG: PF-04217329 - High Dose
DRUG: Latanoprost 0.005%
DRUG: PF-04217329 - Low Dose
DRUG: Latanoprost 0.005%
DRUG: PF-04217329 - Middle Dose
DRUG: Latanoprost 0.005%
DRUG: PF-04217329 - High Dose
DRUG: Latanoprost 0.005%

Sponsor

Pfizer